These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 8470050
1. Potentiating effect of clopidogrel and SR 46349, a novel 5-HT2 antagonist, on streptokinase-induced thrombolysis in the rabbit. Herbert JM, Bernat A, Sainte-Marie M, Dol F, Rinaldi M. Thromb Haemost; 1993 Mar 01; 69(3):268-71. PubMed ID: 8470050 [Abstract] [Full Text] [Related]
5. Clopidogrel versus prasugrel in rabbits. Effects on thrombosis, haemostasis, platelet function and response variability. Wong PC, Crain EJ, Watson CA, Hua J, Schumacher WA, Rehfuss R. Thromb Haemost; 2009 Jan 01; 101(1):108-15. PubMed ID: 19132196 [Abstract] [Full Text] [Related]
7. Comparative immunogenicity and thrombolytic properties toward arterial and venous thrombi of streptokinase and recombinant staphylokinase in baboons. Collen D, De Cock F, Stassen JM. Circulation; 1993 Mar 01; 87(3):996-1006. PubMed ID: 8443918 [Abstract] [Full Text] [Related]
8. Comparative fibrinolytic properties of staphylokinase and streptokinase in animal models of venous thrombosis. Lijnen HR, Stassen JM, Vanlinthout I, Fukao H, Okada K, Matsuo O, Collen D. Thromb Haemost; 1991 Oct 01; 66(4):468-73. PubMed ID: 1796398 [Abstract] [Full Text] [Related]
9. Effect of ticlopidine on streptokinase-induced thrombolysis in rats. Gryglewski RJ, Korbut R, Swies J, Uracz W. Wien Klin Wochenschr; 1999 Feb 12; 111(3):98-102. PubMed ID: 10093891 [Abstract] [Full Text] [Related]
10. SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosis. Visconte C, Sainte-Marie M, Lorrain J, Millet L, O'Connor SE, Schaeffer P, Herbert JM. J Thromb Haemost; 2004 Apr 12; 2(4):629-36. PubMed ID: 15102019 [Abstract] [Full Text] [Related]
11. Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbits. Wong PC, Crain EJ, Watson CA, Jiang X, Hua J, Bostwick JS, Ogletree ML, Schumacher WA, Rehfuss R. J Cardiovasc Pharmacol; 2007 May 12; 49(5):316-24. PubMed ID: 17513951 [Abstract] [Full Text] [Related]
12. Thrombolysis by thienopyridines and their congeners. Gryglewski RJ, Dupin JP, Uracz W, Swiês J, Madej J, Hou G, Gravier D, Casadebaig F. J Physiol Pharmacol; 2000 Dec 12; 51(4 Pt 1):683-93. PubMed ID: 11192941 [Abstract] [Full Text] [Related]
13. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke? Hermann A, Dzialowski I, Koch R, Gahn G. J Neurol Sci; 2009 Sep 15; 284(1-2):155-7. PubMed ID: 19473668 [Abstract] [Full Text] [Related]
14. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism. Mühl D, Füredi R, Gecse K, Ghosh S, Falusi B, Bogár L, Roth E, Lantos J. Blood Coagul Fibrinolysis; 2007 Oct 15; 18(7):661-7. PubMed ID: 17890954 [Abstract] [Full Text] [Related]
15. The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat. Herbert JM, Bernat A, Samama M, Maffrand JP. Thromb Haemost; 1996 Jul 15; 76(1):94-8. PubMed ID: 8819259 [Abstract] [Full Text] [Related]
16. Effects of SanOrg123781A, a synthetic hexadecasaccharide, in a mouse model of electrically induced carotid artery injury: synergism with the antiplatelet agent clopidogrel. Lorrain J, Lechaire I, Gauffeny C, Masson R, Roome N, Herault JP, O'Connor SE, Schaeffer P, Herbert JM. J Pharmacol Exp Ther; 2004 Apr 15; 309(1):235-40. PubMed ID: 14718579 [Abstract] [Full Text] [Related]
17. Protein disulphide isomerase-mediated LA419- NO release provides additional antithrombotic effects to the blockade of the ADP receptor. Vilahur G, Pena E, Padró T, Badimon L. Thromb Haemost; 2007 Apr 15; 97(4):650-7. PubMed ID: 17393029 [Abstract] [Full Text] [Related]